Skip to main content
Journal cover image

Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study.

Publication ,  Journal Article
Campbell, KB; Eickman, SD; Truong, T; Black-Maier, E; Barnett, AS; Wang, A; Green, CL; Daubert, JP; Lewis, RK; Atwater, BD; Al-Khatib, SM ...
Published in: Am J Cardiovasc Drugs
November 2023

BACKGROUND: There is evidence to suggest that colchicine reduces the risk of recurrent atrial fibrillation (AF) after catheter ablation; however, the tolerability and safety of colchicine in routine practice is unknown. METHODS: Patients undergoing catheter ablation for AF who received colchicine after ablation were matched 1:1 to patients who did not by age, sex, and renal function. Recurrent AF was compared between groups categorically at 12 months and via propensity weighted Cox proportional hazards models with and without a 3-month blanking period. RESULTS: Overall, 180 patients (n = 90 colchicine and n = 90 matched controls) were followed for a median (Q1, Q3) of 10.3 (7.0, 12.0) months. Mean age was 65.3 ± 9.1 years, 33.9% were women, mean CHA2DS2-VASc score was 2.9 ± 1.5, and 51.1% had persistent AF. Most patients (70%) received colchicine 0.6 mg daily for a median of 30 days. In the colchicine group, 55 patients (61.1%) were receiving at least one known interacting medication with colchicine. After ablation, one patient required colchicine dose reduction and four patients required discontinuation. After adjusting for covariate imbalance using propensity weighting, no significant association between colchicine use and AF recurrence was identified (adjusted hazard ratio 0.94, 95% confidence interval [CI] 0.48-1.85; p = 0.853). No significant association was found between colchicine use and all-cause hospitalizations (adjusted odds ratio 0.74, 95% CI 0.28-1.96; p = 0.548). CONCLUSION: Despite the frequent presence of drug-drug interactions, a 30-day course of colchicine is well-tolerated after AF ablation; however, we did not observe any association between colchicine and lower rates of AF recurrence or hospitalization.

Duke Scholars

Published In

Am J Cardiovasc Drugs

DOI

EISSN

1179-187X

Publication Date

November 2023

Volume

23

Issue

6

Start / End Page

709 / 719

Location

New Zealand

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Recurrence
  • Middle Aged
  • Male
  • Humans
  • Female
  • Colchicine
  • Catheter Ablation
  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Campbell, K. B., Eickman, S. D., Truong, T., Black-Maier, E., Barnett, A. S., Wang, A., … Piccini, J. P. (2023). Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study. Am J Cardiovasc Drugs, 23(6), 709–719. https://doi.org/10.1007/s40256-023-00612-6
Campbell, Kristen Bova, Stephanie Dougherty Eickman, Tracy Truong, Eric Black-Maier, Adam S. Barnett, Allen Wang, Cynthia L. Green, et al. “Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study.Am J Cardiovasc Drugs 23, no. 6 (November 2023): 709–19. https://doi.org/10.1007/s40256-023-00612-6.
Campbell KB, Eickman SD, Truong T, Black-Maier E, Barnett AS, Wang A, et al. Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study. Am J Cardiovasc Drugs. 2023 Nov;23(6):709–19.
Campbell, Kristen Bova, et al. “Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study.Am J Cardiovasc Drugs, vol. 23, no. 6, Nov. 2023, pp. 709–19. Pubmed, doi:10.1007/s40256-023-00612-6.
Campbell KB, Eickman SD, Truong T, Black-Maier E, Barnett AS, Wang A, Green CL, Daubert JP, Lewis RK, Atwater BD, Al-Khatib SM, Bahnson TD, Thomas KL, Jackson KP, Jackson LR, Pokorney S, Frazier-Mills C, Piccini JP. Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study. Am J Cardiovasc Drugs. 2023 Nov;23(6):709–719.
Journal cover image

Published In

Am J Cardiovasc Drugs

DOI

EISSN

1179-187X

Publication Date

November 2023

Volume

23

Issue

6

Start / End Page

709 / 719

Location

New Zealand

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Recurrence
  • Middle Aged
  • Male
  • Humans
  • Female
  • Colchicine
  • Catheter Ablation
  • Cardiovascular System & Hematology